论文部分内容阅读
目的分析研究疏血通治疗缺血性脑血管病的临床疗效及安全性。方法将76例缺血性脑血管病患者随机分为观察组和对照组各38例,对照组在常规治疗的基础上给予复方丹参注射液,观察组在常规内科治疗的基础上给予疏血通注射液,两组均以14d为1个疗程。观察记录两组临床疗效及不良反应情况。结果观察组总有效率为89.47%,对照组总有效率为55.26%,两组比较差异有统计学意义(P<0.05)。两组治疗前后CSS、MBI评分比较差异有统计学意义(P<0.05)。治疗期间两组均未见明显的不良反应。结论疏血通治疗缺血性脑血管病安全、有效、操作简便,值得在临床进一步推广。
Objective To analyze the clinical efficacy and safety of Shuxuetong in the treatment of ischemic cerebrovascular disease. Methods 76 cases of ischemic cerebrovascular disease were randomly divided into observation group and control group, 38 cases in the control group on the basis of routine treatment given compound Salvia injection, the observation group on the basis of conventional medical treatment given Shu Injection, two groups were 14d for a course of treatment. Observed and recorded two groups of clinical efficacy and adverse reactions. Results The total effective rate was 89.47% in the observation group and 55.26% in the control group, with significant difference between the two groups (P <0.05). The CSS and MBI scores of two groups before and after treatment were significantly different (P <0.05). No significant adverse reactions were seen in both groups during treatment. Conclusion Shuxuetong treatment of ischemic cerebrovascular disease safe, effective, easy to operate, it is worth further promotion in the clinical.